Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 1, 2006, Pages 25-30

  Hoe, Francis M ^a   Charron, Martin ^b   Moshang, Thomas Jr ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adolescent; Child; Differentiated thyroid carcinoma; Radionuclide imaging; Recombinant human thyrotropin; Thyroglobulin; Thyroid neoplasm; Tumor markers

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; TUMOR MARKER;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISEASE SURVEILLANCE; FEMALE; HORMONE METABOLISM; HUMAN; MALE; RADIOFREQUENCY ABLATION; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

EID: 32944466892     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.1.25     Document Type: Article

References (16)

1. National Cancer Institute SEER (Surveillance, Epidemiology, and End Results) Program. Age-adjusted and age-specific SEER cancer incidence rates, 1975-2001. In: http://seer.cancer.gov/csr/1975_2001/ sections.html; 2001.
2. Foley T, Malvaux P, Blizzard R. Thyroid disease. In: Kappy MS, Blizzard RM, Migeon CJ, eds. Wilkins The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, 4th Ed. Springfield, IL: Charles C. Thomas, 1994; 459-523.
3. Mazzaferri EL. VII. Thyroid diseases: tumors. 77. Carcinoma of follicular epithelium. Radioiodine and other treatment and outcomes. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text 8th Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2000; 904-929.
4. Koch CA, Sarlis NJ. The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management. J Endocrinol Invest 2001; 24: 659-675.
5. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated non-medullary thyroid cancer: a review. Thyroid 2002; 12: 683-702.
6. Sklar CA, La Quaglia MD. Thyroid cancer in children and adolescents. In: Radovick S, MacGillivray MH, eds. Pediatric Endocrinology: A Practical Clinical Guide. Totowa, NJ: Humana Press Inc., 2003; 327-329.
7. Bauer AJ, Tuttle RM, Francis GL. Differentiated thyroid carcinoma of children and adolescents. Endocrinologist 2002; 12:135-142.
8. Mazzaferri EL, Robbins RJj Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 1433-1441.
9. Pacini F. Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab 200 1; 86: 5686-5690.
10. Robbins RJ, Robbins AK. Recombinant human thyrotropin and thyroid cancer management. J Clin Endocrinol Metab 2003; 88: 1933-1938.
11. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84: 3877-3885.
12. Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 200 1; 86: 619-625.
13. Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 2002; 87: 1490-1498.
14. Haugen BR, Ridgeway EC, McLaughlin BA, McDermott MT. Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin. Thyroid 2002; 12:37-43.
15. Antonelli A, Miccoli P, Fallahi P, Grosso M, Nesti C, Spinelli C, Ferrannini E. Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 2003; 13: 479-484.
16. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121-1127.